Back

Target / Pathway

Ln-303 Appetite Regulator

Therapeutic Area

Appetite Regulation, Obesity

Appetite Regulating Peptide

Buccal Ln-303 Peptide Analog

Before lowering the national standard on the height weight ratio, the U.S. army had not been able to hit its hiring targets for recruits for years. The current geopolitical climate requires a reinstatement of more stringent requirements on recruits and warfighters. Currently, 19-22% of active-duty members are classified as obese, leaving service 18 months earlier on average.

Back to Portfolio

Military spent over $6 billion between 2022 and 2025 on bonuses and advertising to bridge the gap.

Our solution involves an appetite suppressant that acts directly on the nervous system. Legion functions unlike GLP1 family drugs, which are generally injectable systemic drugs that have side effects to make you feel so bad you don’t want to eat. Legion directly works on the nervous system without these canonical downsides.